UNH - UnitedHealth Group Incorporated
NYSE
->
Healthcare
->
Healthcare Plans
Minnetonka,
United States
Type: Equity
UNH price evolution
UNH
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $26286 | $28414 | $25427 | |
| Short term investments | $8451 | $7915 | $7956 | |
| Net receivables | $49877 | $19284 | $38970 | |
| Inventory | ||||
| Total current assets | $92038 | $25416 | $78437 | |
| Long term investments | $46113 | $45928 | $47609 | |
| Property, plant & equipment | $9801 | $10429 | $11450 | |
| Goodwill & intangible assets | $120165 | $121207 | $118926 | |
| Total noncurrent assets | $194018 | $195268 | $195283 | |
| Total investments | $54564 | $53843 | $55565 | |
| Total assets | $299309 | $286056 | $284210 | $273720 |
| Current liabilities | ||||
| Accounts payable | $63433 | $30738 | $64353 | |
| Deferred revenue | $2572 | $3206 | $3355 | |
| Short long term debt | $11371 | $9787 | $4274 | |
| Total current liabilities | $3909 | $11371 | $9787 | $4274 |
| Long term debt | $74101 | $63727 | $63850 | $58263 |
| Total noncurrent liabilities | $82152 | $82861 | $75747 | |
| Total debt | $75098 | $73637 | $62537 | |
| Total liabilities | $199428 | $191380 | $191840 | $179299 |
| Shareholders' equity | ||||
| Retained earnings | $92400 | $90118 | $95774 | |
| Other shareholder equity | $99881 | $94676 | $92370 | $94421 |
| Total shareholder equity | $89359 | $86688 | $88756 | |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $25427 | $23365 | $21375 | $16921 |
| Short term investments | $7956 | $8633 | $6981 | $6936 |
| Net receivables | $38970 | $12769 | $28082 | $25404 |
| Inventory | ||||
| Total current assets | $78437 | $19390 | $61758 | $53718 |
| Long term investments | $47609 | $43728 | $43114 | $41242 |
| Property, plant & equipment | $11450 | $10128 | $8969 | $8626 |
| Goodwill & intangible assets | $118926 | $107753 | $85839 | $82193 |
| Total noncurrent assets | $195283 | $176636 | $150448 | $143571 |
| Total investments | $55565 | $52361 | $50095 | $48178 |
| Total assets | $273720 | $245705 | $212206 | $197289 |
| Current liabilities | ||||
| Accounts payable | $64353 | $27715 | $49126 | $44367 |
| Deferred revenue | $3355 | $3075 | $2571 | $2842 |
| Short long term debt | $4274 | $3110 | $3620 | $4819 |
| Total current liabilities | $4274 | $3110 | $78292 | $72420 |
| Long term debt | $58263 | $54513 | $42383 | $38648 |
| Total noncurrent liabilities | $75747 | $70121 | $57435 | $54330 |
| Total debt | $62537 | $57623 | $46003 | $43467 |
| Total liabilities | $179299 | $164255 | $135727 | $126750 |
| Shareholders' equity | ||||
| Retained earnings | $95774 | $86156 | $77134 | $69295 |
| Other shareholder equity | $94421 | $81450 | -$5384 | -$3814 |
| Total shareholder equity | $88756 | $77772 | $71760 | $65491 |
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $100820 | $99796 | ||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $92112 | $91865 | ||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $1356 | $1222 | ||
| Interest expense | -$1074 | -$844 | ||
| Net income | ||||
| Net income | $6055 | -$1409 | ||
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $371622 | $324162 | $257141 | |
| Cost of revenue | $244545 | $190141 | ||
| Gross Profit | $79617 | $67000 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $47782 | $41704 | ||
| Total operating expenses | $339264 | $51182 | $44595 | |
| Operating income | $28435 | $22405 | ||
| Income from continuing operations | ||||
| EBIT | $27916 | $22039 | ||
| Income tax expense | $5968 | $5704 | $4973 | |
| Interest expense | -$3246 | $2092 | $1663 | |
| Net income | ||||
| Net income | $22381 | $20120 | $15403 | |
| Income (for common shares) | $20120 | $15403 | ||
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$19408 | -$13757 | -$6340 | -$15574 |
| Financing activities | ||||
| Dividends paid | -$5601 | -$3664 | -$1729 | -$6761 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $4830 | $7035 | $8231 | -$11529 |
| Effect of exchange rate | -$30 | -$44 | -$48 | $97 |
| Change in cash and equivalents | $6973 | $859 | $2987 | $2062 |
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $20120 | $17285 | $15403 | |
| Operating activities | ||||
| Depreciation | $3400 | $3103 | $2891 | |
| Business acquisitions & disposals | -$18044 | -$4821 | -$7139 | |
| Stock-based compensation | $925 | $800 | $679 | |
| Total cash flows from operations | $26206 | $22343 | $22174 | |
| Investing activities | ||||
| Capital expenditures | -$2802 | -$2454 | -$2051 | |
| Investments | -$6837 | -$1843 | -$2836 | |
| Total cash flows from investing | -$15574 | -$28476 | -$10372 | -$12532 |
| Financing activities | ||||
| Dividends paid | -$6761 | -$5991 | -$5280 | -$4584 |
| Sale and purchase of stock | -$5747 | -$3645 | -$2810 | |
| Net borrowings | $12536 | $2481 | $2586 | |
| Total cash flows from financing | -$11529 | $4226 | -$7455 | -$3590 |
| Effect of exchange rate | $97 | $34 | -$62 | -$116 |
| Change in cash and equivalents | $2062 | $1990 | $4454 | $5936 |
News
Fundamentals
| Market cap | $334.74B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 923.42M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 2.02 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |